We're passionate about the early detection of TBI

BrainScope Company, Inc. is a medical neuro-technology company that is pioneering the future of traumatic brain injury (TBI) assessment. The company’s innovative BrainScope One system (FDA cleared as Ahead 300) is an easy-to-use, non-invasive, hand-held platform that empowers physicians to make more accurate TBI assessments quickly and at the point-of-care. BrainScope’s unique system leverages advanced digital signal processing, sophisticated algorithms and machine learning technologies to identify and evaluate key brain electrical activity biomarkers of TBI. BrainScope One also includes digitized versions of standard clinical assessments for milder forms of TBI known as concussion.

Results from clinical studies utilizing BrainScope’s technology have been independently published through 23 articles in leading peer-reviewed neurotrauma and emergency medicine journals.

BrainScope has been awarded more than $27 million of U.S. Department of Defense research contracts for the development of its TBI and concussion assessment technology and has received two awards from GE and the NFL through its Head Health Challenge I.  The company has received significant funding from private investors including Revolution (created by AOL co-founder Steve Case), State of Maryland Venture Fund, ZG Ventures, Brain Trust Accelerator Fund, Difference Capital and DBL Partners.


board of directors

 
Daniel J. Moore Chairman

Daniel J. Moore
Chairman

Jean Case

Jean Case

Miles R. Gilburne  

Miles R. Gilburne
 

James B. Peake, M.D. LTG (Ret)

James B. Peake, M.D. LTG (Ret)

 
 
John M. Reher

John M. Reher

Cynthia Ringo

Cynthia Ringo

Michael E. Singer

Michael E. Singer

Gail R. Wilensky, Ph.D.

Gail R. Wilensky, Ph.D.

 

Management

 
Michael E. Singer  Chief Executive Officer

Michael E. Singer 
Chief Executive Officer

Andrew Holman Chief Commercial Officer

Andrew Holman
Chief Commercial Officer

Leslie S. Prichep, Ph.D. Chief Scientific Officer

Leslie S. Prichep, Ph.D.
Chief Scientific Officer

Laurie Silver Chief Financial Officer

Laurie Silver
Chief Financial Officer

 
 
Doug Oberly Vice President of Clinical Affairs

Doug Oberly
Vice President of Clinical Affairs

Mark Valentine Vice President of Sales & Sales Operations

Mark Valentine
Vice President of Sales & Sales Operations

 

OUR INVESTORS

 
 
 
DBL Partners.jpg

CLINICAL PARTNERS

 
 

DEVELOPMENT PARTNERS